AF12198 Ac-FEWTPGWYQJYALPL-amide

  • Description

  • Application Data

Description

Selective receptor antagonist to the human cytokine, type 1 interleukin-1 (IL-1)

See full description

Application Data

Catalogue number crb1001289
Molecular Weight 1895.9
Sequence (one letter code) Ac-FEWTPGWYQJYALPL-amide
Sequence (three letter code)

Ac-Phe-Glu-Trp-Thr-Pro-Gly-Trp-Tyr-Gln-J-Tyr-Ala-Leu-Pro-Leu-NH2

Aliase IL-1ra, Ac-FEWTPGWYQXYALPL-amide
Modifications Where J is unnatural amino acid 2-azetidine-1-carboxylic acid
Purity >95%
cas 185413-30-3
Storage -20°C
References

Yan et al (2017) Chronic pain and impaired glial glutamate transporter function in lupus-prone mice are ameliorated by blocking macrophage colony-stimulating factor-1 receptors. J. Neurochem. 140(6) 963 PMID: 28072466

Akeson et al (1996) AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1. J Biol. Chem. 271(48) 30517 PMID: 8940020

Manufactured in: United Kingdom
Data Sheet Material Safety Data Sheet (MSDS)

AF12198 is a selective receptor antagonist to the human cytokine, type 1 interleukin-1 (IL-1) and thus blocks IL-1β signalling. AF12198 can inhibit IL-1-induced IL-8 production by human dermal fibroblasts and IL-1-induced intercellular adhesion molecule-1 (ICAM-1) expression by endothelial cells. AF12198 also blocks IL-1 induction of IL-6 and down regulates IL-6 induction in monkeys. AF12198 does not bind the human type II IL-1 receptor, or the murine type I IL-1 receptor.

IL-1 influences a wide range of immune and inflammatory responses. Sustained expression of even low levels of IL-1 can be harmful in chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease

AF12198

Cat No.Pack SizePriceQty.
0.5mg£190.00
1mg£260.00
5mg£550.00
10mg£750.00
Bulk Quote